These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7624955)

  • 1. Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy.
    Abouljoud MS; Deierhoi MH; Hudson SL; Diethelm AG
    Transplantation; 1995 Jul; 60(2):138-44. PubMed ID: 7624955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal retransplants: effect of primary allograft nephrectomy on early function, acute rejection and outcome.
    Douzdjian V; Rice JC; Carson RW; Gugliuzza KK; Fish JC
    Clin Transplant; 1996 Apr; 10(2):203-8. PubMed ID: 8664520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does nephrectomy of failed allograft influence graft survival after re-transplantation?
    Ahmad N; Ahmed K; Mamode N
    Nephrol Dial Transplant; 2009 Feb; 24(2):639-42. PubMed ID: 18852188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term kidney regraft survival from deceased donors: risk factors and outcomes in a single center.
    Arnol M; Prather JC; Mittalhenkle A; Barry JM; Norman DJ
    Transplantation; 2008 Oct; 86(8):1084-9. PubMed ID: 18946346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of late allograft nephrectomy.
    Madore F; Hébert MJ; Leblanc M; Girard R; Bastien E; Morin M; Beaudry C; Boucher A; Dandavino R
    Clin Nephrol; 1995 Nov; 44(5):284-9. PubMed ID: 8605707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal allograft failure after simultaneous pancreas-kidney transplantation: univariate and multivariate analyses of donor and recipient risk factors.
    Douzdjian V; Rice JC; Carson RW; Gugliuzza KG; Fish JC
    Clin Transplant; 1996 Jun; 10(3):271-7. PubMed ID: 8826665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing second renal allograft survival: a single center experience in China.
    Wang D; Xu TZ; Chen JH; Wu WZ; Yang SL; Lin WH; Cai JQ; Tan JM
    Transpl Immunol; 2009 Jan; 20(3):150-4. PubMed ID: 18848988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadaver-donor renal retransplants.
    Cho YW; Cecka JM
    Clin Transpl; 1993; ():469-84. PubMed ID: 7918181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney allograft outcome in simultaneous pancreas-kidney transplantation.
    Nakache R; Weinbroum A; Merhav H; Kaplan E; Kariv Y; Khoury W; Gutman M; Klausner JM
    Isr Med Assoc J; 2000 Jul; 2(7):517-9. PubMed ID: 10979325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated HLA mismatches and second renal graft survival in centers of the South-Eastern Organ Procurement Foundation.
    Heise ER; Thacker LR; MacQueen JM; Peters TG
    Clin Transplant; 1996 Dec; 10(6 Pt 2):579-85. PubMed ID: 8996746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant risk factors for renal allograft dysfunction at one year in Indian patients.
    Prabhu R; John GT; Shankar V; Thomas PP; Abi Abraham M; Jeyaseelan L; Jacob CK
    Natl Med J India; 2001; 14(1):18-21. PubMed ID: 11242692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreas transplantation in the United States as reported to the United Network for Organ Sharing (UNOS) and analyzed by the International Pancreas Transplant Registry.
    Sutherland DE; Gruessner A
    Clin Transpl; 1995; ():49-67. PubMed ID: 8794254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.